High Dose Cyclophosphamide Plus Recombinant Human Granulocyte-colony Stimulating Factor (rhG-CSF) in the Treatment of Follicular, Low Grade Non-Hodgkin's Lymphoma: CALGB 9150
暂无分享,去创建一个
J. Sklar | R. Schilsky | G. Petroni | D. Niedzwiecki | B. Peterson | M. Barcos | S. Lichtman | Jeffrey L. Johnson | R. T. Perri | J. Johnson | Richard L. Schilsky | Jeffrey Sklar | Stuart M. Lichtman
[1] J. Armitage,et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] L. Gordon,et al. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] R. Levy,et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] M. M. Mac Manus,et al. Overview of treatment of localized low-grade lymphomas. , 1997, Hematology/oncology clinics of North America.
[5] A. Markham,et al. Fludarabine , 2012, Drugs.
[6] James Olen Armitage,et al. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. , 1997, Blood.
[7] J. Armitage,et al. High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] E. Deconinck,et al. Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage 111-IV patients , 1997 .
[9] J. Vose,et al. 2-Chlorodeoxyadenosine as initial therapy for advanced low grade lymphomas. , 1997, Leukemia & lymphoma.
[10] J. Gribben,et al. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. , 1996, Blood.
[11] P. Morel,et al. Autologous bone marrow transplantation as consolidation therapy may prolong remission in newly diagnosed high-risk follicular lymphoma: a pilot study of 34 cases. , 1995, Leukemia.
[12] Emili Montserrat,et al. A predictive model for aggressive non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.
[13] J. Gribben,et al. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. , 1991, Blood.
[14] J. Gribben,et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. , 1991, The New England journal of medicine.
[15] W. Velasquez,et al. Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] K. Offit,et al. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. , 1991, Blood.
[17] S. Korsmeyer,et al. Mechanism of the t(14;18) chromosomal translocation: structural analysis of both derivative 14 and 18 reciprocal partners. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[18] C. Bloomfield,et al. There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas. , 1985, Blood.
[19] J. Glick,et al. Nodular mixed lymphoma: results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy. , 1981, Blood.
[20] S. Rosenberg,et al. The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation. , 1981, Blood.
[21] R. Fisher,et al. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup. , 1977, Cancer treatment reports.
[22] S. Rosenberg,et al. Chemotherapy of the non-Hodgkin's lymphomas: the Stanford experience. , 1977, Cancer treatment reports.
[23] S. Rosenberg,et al. Treatment of advanced non-Hodgkin's lymphomas with favorable histologies: preliminary results of a prospective trial. , 1976, Blood.
[24] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .